Traditional methods for assessing treatment response — such as CT imaging and the CA19-9 tumor marker — are often unreliable, especially during immunotherapy, where pseudo-progression can ...

In the present prospective study, we compared various tumor markers (CEA, CA 125, CA 19-9, CA 72-4) in serum and ascites between the three most important etiologies of ascites (tuberculosis, cirrhosis ...

Donald Trump misspoke in off-the-cuff remarks on May 19, saying he felt 'sad' to learn that Joe Biden has 'stage 9' prostate cancer. His comments came one day after Biden revealed he has stage 4 ...

This is the first report linking dulaglutide to abnormal CA 19-9 elevation in the absence of cancer, emphasizing the importance of follow-up and further investigation when faced with rising tumor ...

Background: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are the predominant serum tumour markers (STMs) for predicting the prognosis of colorectal cancer (CRC). The objective ...

CA 19-9 is widely used as a tumor marker related to pancreatic ductal adenocarcinoma. Pancreatic cancer (PC) is the fourth leading cause of cancer deaths worldwide, with a 5-year survival rate of less ...

In the clinical trials, AlGaN/GaN HEMT biosensors were successfully investigated for the rapid detection of CA 19-9 tumor markers. Our strategy involves using a normalized resistance change ratio, ...

A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer ...

Article Title Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...